Stanley-Laman Group, Ltd. - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
Stanley-Laman Group, Ltd. ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$4,304,000
+77.9%
316,933
-0.7%
1.04%
+41.0%
Q1 2020$2,419,000
+22.4%
319,073
+2.1%
0.73%
+57.5%
Q4 2019$1,976,000
+61.3%
312,6090.0%0.47%
+54.3%
Q3 2019$1,225,000
-19.0%
312,6090.0%0.30%
-16.8%
Q2 2019$1,513,000
-40.9%
312,6090.0%0.36%
-41.6%
Q1 2019$2,560,000
+38.5%
312,609
-6.5%
0.62%
+21.2%
Q4 2018$1,849,000
-30.5%
334,328
+11.0%
0.51%
-21.4%
Q3 2018$2,659,000
-22.0%
301,182
-11.8%
0.65%
-14.6%
Q2 2018$3,408,000
+13.8%
341,489
+8.6%
0.76%
+12.2%
Q1 2018$2,996,000314,4010.68%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$10,515,00010.70%
Orchard Capital Management, LLC 1,593,531$3,601,0001.06%
Nantahala Capital Management 4,918,565$11,116,0000.39%
Ardent Capital Management, Inc. 168,811$382,0000.25%
Birchview Capital, LP 100,000$226,0000.15%
Nantahala Capital Management 1,000,000$2,260,0000.08%
PDT Partners, LLC 433,400$979,0000.08%
Woodline Partners LP 2,231,966$5,044,0000.07%
Virtus ETF Advisers LLC 69,015$156,0000.06%
JACOBS LEVY EQUITY MANAGEMENT, INC 2,737,900$6,188,0000.04%
View complete list of AKEBIA THERAPEUTICS INC shareholders